Current status and perspectives in immunotherapy for metastatic melanoma-Reference-Cited by-同舟云学术

Current status and perspectives in immunotherapy for metastatic melanoma

Published:2018-01-03 Issue:15 Volume:9 Page:12452-12470
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Marconcini Riccardo¹,Spagnolo Francesco²,Stucci Luigia Stefania³,Ribero Simone⁴,Marra Elena⁴,De Rosa Francesco⁵,Picasso Virginia²,Di Guardo Lorenza⁶,Cimminiello Carolina⁶,Cavalieri Stefano⁶,Orgiano Laura⁷,Tanda Enrica²,Spano Laura²,Falcone Alfredo¹,Queirolo Paola²,

Affiliation:

1. Unit of Medical Oncology 2, Azienda Ospedaliera-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy

2. Department of Medical Oncology, IRCCS AOU San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

3. Medical Oncology Unit, Department of Biomedical Sciences and Clinical Oncology, University of Bari, Bari, Italy

4. Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy

5. Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST IRCCS, Meldola, Italy

6. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

7. AOU Cagliari, Department of Medical Oncology, University of Cagliari, Cagliari, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features;Medicina;2024-07-30

2. Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives;International Journal of Molecular Sciences;2024-06-30

3. Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling;Cancers;2024-06-18

4. Immune checkpoint inhibitors in metastatic melanoma therapy (Review);Medicine International;2024-02-09

5. Nano‐Mediated PDT as a Multifunctional Immunomodulatory Agent in the Intricate Milieu of Melanoma;Advanced Therapeutics;2024-01-28